Concepedia

Natalie R. Hagen

NR

Statistics

Publications

6

Citations

339

H-Index

6

Active since

2020

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Natalie R. Hagen is an author at National Center for Advancing Translational Sciences specializing in viral pathogenesis, signal transduction, and drug discovery.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro

Qi Zhang, Catherine Zhengzheng Chen, Manju Swaroop et al. · Cell Discovery · 2020 · 240 citations · Full text

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment

Amy Q. Wang, Natalie R. Hagen, Elias Carvalho Padilha et al. · Frontiers in Pharmacology · 2022 · 28 citations · Full text

Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates

Rintaro Kato, Wenyu Zeng, Vishal B. Siramshetty et al. · Frontiers in Pharmacology · 2023 · 25 citations · Full text

Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketamines

Jaclyn N. Highland, Patrick J. Morris, Kylie M. Konrath et al. · ACS Chemical Neuroscience · 2022 · 23 citations · Full text

Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs <i>in vitro</i>

Qi Zhang, Catherine Z. Chen, Manju Swaroop et al. · 2020 · 13 citations · Full text

, , +13

Rows per page

1–5 of 6